ContraFect (CFRX) Enters Warrant Exercise Transaction for Proceeds of $9.6M Jun 27, 2023 08:33AM
ContraFect Enters Into a Warrant Exercise Transaction for Proceeds of $9.6 Million Jun 27, 2023 08:30AM
ContraFect (CFRX) Prices $10M Share Offering at $4/sh, Announces Concurrent Private Placement Feb 28, 2023 08:31AM
ContraFect Announces Pricing of $10.0 Million Registered Direct Offering and Concurrent Private Placement Feb 28, 2023 08:30AM
ContraFect (CFRX) Announces Pricing of $7.0 Million Registered Direct Offering and Concurrent Private Placement Dec 13, 2022 08:05AM


Dec 13, 2022 08:01AM ContraFect Announces Pricing of $7.0 Million Registered Direct Offering and Concurrent Private Placement
Mar 21, 2022 08:30AM ContraFect to Present at the Maxim Group 2022 Virtual Growth Conference
Mar 22, 2021 04:05PM ContraFect Corporation Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Mar 18, 2021 06:03AM ContraFect (CFRX) Prices 10M Share Common Offering at $5/Sh
Mar 17, 2021 11:00PM ContraFect Corporation Prices Public Offering of Common Stock
May 22, 2020 06:02AM ContraFect (CFRX) Prices 11.797M Share & Warrants Offering at $4.90/Sh
May 21, 2020 10:59PM ContraFect Corporation Prices Approximately $52.5 Million Public Offering of Common Stock and Warrants
Apr 21, 2020 07:00AM ContraFect Announces Dr. Roger J. Pomerantz, Chief Executive Officer and Chairman, Invited as Keynote Speaker and Presenter in Maxim’s Infectious Disease Virtual Conference
Feb 24, 2020 11:22AM ContraFect Corp. (CFRX) PT Raised to $22 at Maxim Group
Dec 17, 2019 09:25AM ContraFect Corporation Prices Approximately $10 Million Public Offering of Common Stock
Dec 10, 2019 08:53AM ContraFect (CFRX) Prices Approximately $10 Million Public Offering of Common Stock and Concurrent $3 Million Private Placement of Common Stock to Pfizer
Dec 10, 2019 08:46AM ContraFect Corporation Prices Approximately $10 Million Public Offering of Common Stock and Concurrent $3 Million Private Placement of Common Stock to Pfizer
Dec 9, 2019 04:04PM ContraFect (CFRX) Announces Proposed Common Share Offering & Concurrent Private Placement of Common Share to Pfizer Inc. (PFE)
Dec 9, 2019 04:03PM ContraFect Corporation Announces Proposed Public Offering of Common Stock and Concurrent Private Placement of Common Stock to Pfizer Inc.
Jun 11, 2019 07:35AM Maxim Group Starts ContraFect Corp. (CFRX) at Buy
May 3, 2019 09:19AM Maxim Group Assumes ContraFect Corp. (CFRX) at Buy
Apr 19, 2017 02:07PM Maxim Group Maintains Hold Rating on ContraFect (CFRX); New CF-301 Data to be Presented at ECCMID
Mar 15, 2016 10:22AM ContraFect (CFRX) PT Trimmed to $7 at Maxim Group as Results Awaited
Dec 31, 2015 07:05AM ContraFect (CFRX) PT Cut to $9 at Maxim Group; 'Buy' Maintained